Tumor selectivity of stealth multi-functionalized superparamagnetic iron oxide nanoparticles

Area of Science:

• Biomedical Engineering
• Nanotechnology
• Materials Science

Background:

• Superparamagnetic iron oxide nanoparticles (SPIO-NPs) are established MRI contrast agents for passive disease imaging.
• There is growing interest in developing SPIO-NPs for active, cell-specific targeting in imaging and drug delivery.
• Current SPIO-NP applications are limited by biocompatibility and non-specific uptake by the reticuloendothelial system (RES).

Purpose of the Study:

• To engineer a novel active tumor-targeting SPIO-NP system.
• To enhance SPIO-NP biocompatibility and tumor cell specificity using o-carboxymethyl chitosans (OCMCS) and folic acid (FA).
• To evaluate the potential of FA-OCMCS-SPIO-NPs for improved MRI imaging, drug delivery, and hyperthermia.

Main Methods:

• Surface modification of SPIO-NPs with OCMCS and FA.
• In vitro assessment of nano-cytotoxicity and macrophage cell uptake.
• Evaluation of nanoparticle uptake by folate receptor (FR)-positive and FR-negative tumor cell lines.
• In vivo MRI imaging and tumor histological analysis of FA-OCMCS-SPIO-NPs.

Main Results:

• OCMCS surface modification significantly reduced SPIO-NP cytotoxicity and macrophage capture.
• Folic acid modification enhanced nanoparticle uptake in FR-positive tumor cells, with minimal effect on other cell types.
• FA-OCMCS-SPIO-NPs demonstrated effective in vivo targeting of FR-positive tumor cells via MRI and histology.

Conclusions:

• OCMCS and FA surface modification significantly improve SPIO-NP biocompatibility.
• The FA-OCMCS-SPIO-NP system exhibits enhanced targeting of folate receptor-positive tumors.
• This modified SPIO-NP system holds promise for advanced MRI imaging, targeted drug delivery, and hyperthermia applications.